Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Transitional Cell × obinutuzumab × 90 days × Clear all

Sponsor

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 22 Lymphoma, Non-Hodgkin 10 Lymphoma, Follicular 8 Lymphoma 7 Lymphoma, Mantle-Cell 6 Lymphoma, Large B-Cell, Diffuse 5 Recurrence 4 Neoplasms 3 Lymphoma, B-Cell, Marginal Zone 3 Lymphoma, B-Cell 3 Leukemia, Hairy Cell 2 Leukemia 2 Burkitt Lymphoma 2 Neoplasm, Residual 1 Lymphatic Diseases 1 Leukemia, B-Cell 1 Heart Failure 1 Extensive Stage Small Cell Lung Cancer 1 Dendritic Cell Sarcoma, Interdigitating 1 Cytokine Release Syndrome 1

Interventions

pembrolizumab 22 enfortumab vedotin 14 Magnetic Resonance Spectroscopy 10 Specimen Handling 9 Nivolumab 9 Gemcitabine 9 avelumab 8 Cisplatin 8 atezolizumab 7 Carboplatin 7 sacituzumab govitecan 5 Docetaxel 5 Ipilimumab 4 durvalumab 3 Paclitaxel 3 lenvatinib 2 erdafitinib 2 dodecyl maltoside 2 cabozantinib 2 Taxes 2 Mitomycin 2 Immunoglobulin G 2 Fluorodeoxyglucose F18 2 CTLA-4 Antigen 2 Biopsy 2 ALT-803 2 zimberelimab 1 zanidatamab 1 toripalimab 1 tocilizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡